Steven Kelly - Jun 6, 2023 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
President and CEO, Director
Signature
/s/ Richard Morris, as Attorney-in-Fact for Steven Kelly
Stock symbol
CARM
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/8/2023, 06:20 PM
Previous filing
Mar 9, 2023
Next filing
Jul 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +600K $0.00 600K Jun 6, 2023 Common Stock 600K $7.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over four years, with 25% of the shares vesting on June 6, 2024 and the remaining shares vesting over the next three years thereafter in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.